Patent Assignment
Reel/Frame 029441/0607
Security Agreement
Recorded: 2012-12-10
Pages: 18
Assignor
EXPRESSION PATHOLOGY INCORPORATED
Executed: 2012-12-06
Assignees
CALIFORNIA CAPITAL EQUITY LLC
11755 WILSHIRE BOULEVARD, SUITE 2000, LOS ANGELES, CALIFORNIA, 90025
NANT CAPITAL LLC
11755 WILSHIRE BOULEVARD, SUITE 2000, LOS ANGELES, CALIFORNIA, 90025
Covered Properties
(43)
Liquid Tissue Preparation From Histopathologically Processed Biological Samples, Tissues and Cells
Diagnosis of Diseases and Conditions by Analysis of Histopathologically Processed Biological Samples Using Liquid Tissue Preparations
Method of Discovering and Analyzing Secreted Biomarkers of Disease from Solid Tissue
Application:
12/666,288 →
Publication:
US 2011/0105337
Biomarkers for Endometrial Disease
Application:
12/937,222 →
Publication:
US 2011/0028344
Method of Assessing the Metastatic Status of a Primary Tumor
Application:
12/294,423 →
Publication:
US 2009/0263842
Urokinase-Type Plasminogen Activator Protein/Plasminogen Activator Inhibitor Type-1 Protein-Selected Reaction Monitoring Assay
Application:
61/348,712 →
c-Src Selected Reaction Monitoring Assay
Application:
61/369,411 →
Her2 and Truncated p95Her2 SRM/MRM Assay
Application:
61/421,206 →
Methods for measuring the level of Insulin-Like Growth Factor 1 Receptor (IGF1R) Protein using SRM/MRM Assay
Insulin Receptor Substrate 1 (IRS1) Protein SRM/MRM Assay
Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM Assay
Epidermal Growth Factor Receptor (EGFR) Protein SRM Assay
Application:
13/529,897 →
Publication:
US 2013/0011408
cMET Protein SRM/MRM Assay
Application:
61/427,396 →
Protein Biomarkers of Recurrent Breast Cancer
Application:
61/428,145 →
Her3 Protein SRM/MRM Assay
Application:
61/428,147 →
Protein Biomarkers of Late Stage Breast Cancer
Application:
61/428,160 →
Bcl-2-Like Protein 11 SRM/MRM Assay
Application:
61/432,462 →
SRM/MRM Assay for the Fatty Acid Synthase Protein
Application:
61/538,091 →
Multiplex MRM Assay for Evaluation of Cancer
Application:
61/537,918 →
MRM/SRM Assay for Death Receptor 5 Protein
Application:
61/538,096 →
SRM/MRM Assay for the Receptor Tyrosine-Protein Kinase erbB-4 Protein (HER4)
Application:
61/543,092 →
SRM/MRM Assay for the Ephrin Type-A Receptor 2 Protein
Application:
61/543,106 →
Liquid Tissue Preparation from Histopathologically Processed Biological Samples, Tissues and Cells
Multiplex Method for Increased Proteomic Coverage from Histopathologically Processed Biological Samples, Tissues Cells
Multiplex Liquid Tissue¿ Method for Increased Proteomic Coverage from Histopathologically Processed Biological Samples, Tissues and Cells
Liquid Tissue Preparation from Histopathologically Processed Biological Samples, Tissues and Cells
PCT:
PCT/US2004/007142 ↗
Multiplex Method for Increased Proteomic Coverage from Histopathologically Processed Biological Samples Using Liquid Tissue Preparations
PCT:
PCT/US2006/020166 ↗
Diagnosis of Deseases and Conditions by Analysis of Histopathologically Processed Biological Samples Using Liquid Tissue Preparations
PCT:
PCT/US2006/020167 ↗
Method of Discovering and Analyzing Secreted Biomarkers of Disease from Solid Tissue
PCT:
PCT/US2008/067937 ↗
Biomarkers for Endometrial Disease
PCT:
PCT/US2009/040399 ↗
Method of Assessing the Metastatic Status of a Primary Tumor
PCT:
PCT/US2007/064924 ↗
Urokinase-Type Plasminogen Activator Protein/Plasminogen Activator Inhibitor Type-1 Protein-Selected Reaction Monitoring Assay
PCT:
PCT/US2011/038196 ↗
C-Src Selected Reaction Monitoring Assay
PCT:
PCT/US2011/045960 ↗
Truncated HER2 Srm/Mrm Assay
PCT:
PCT/US2011/064045 ↗
Insulin-Like Growth Factor 1 Receptor (Igf-1R) Protein Srm/Mrm Assay
PCT:
PCT/US2010/061924 ↗
Insulin Receptor Substrate 1 (IRS1) Protein Srm/Mrm Assay
PCT:
PCT/US2010/061909 ↗
Secreted Protein Acidic and Rich in Cysteine (Sparc) Protein Srm/Mrm Assay
PCT:
PCT/US2010/061925 ↗
Epidermal Growth Factor Receptor (Egfr) Protein Srm/Mrm Assay
PCT:
PCT/US2010/061916 ↗
Cmet Protein Srm/Mrm Assay
PCT:
PCT/US2011/067439 ↗
Protein Biomarkers of Recurrent Breast Cancer
PCT:
PCT/US2011/067996 ↗
HER3 Protein Srm/Mrm Assay
PCT:
PCT/US2011/067998 ↗
Protein Biomarkers of Late Stage Breast Cancer
PCT:
PCT/US2011/068000 ↗
Bcl-2-Like Protein 11 Srm/Mrm Assay
PCT:
PCT/US2012/021283 ↗
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 12, 2004
From: DARFLER, MARLENE M.; KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 015353/0307 →
Assignment of Assignor's Interest
Oct 17, 2008
From: KRIZMAN, DAVID B.; GUIEL, THOMAS G.; DARFLER, MARLENE M.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 021695/0854 →
Assignment of Assignor's Interest
Dec 1, 2008
From: KRIZMAN, DAVID B.; GUIEL, THOMAS G.; DARFLER, MARLENE M.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 021905/0743 →
Assignment of Assignor's Interest
Mar 24, 2009
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 022443/0635 →
Assignment of Assignor's Interest
Mar 24, 2009
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 022471/0836 →
Assignment of Assignor's Interest
Aug 9, 2011
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 026722/0301 →
Assignment of Assignor's Interest
Dec 8, 2011
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 027350/0050 →
Assignment of Assignor's Interest
Jun 5, 2014
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; THYPARAMBIL, SHEENO
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 033043/0195 →
Assignment of Assignor's Interest
Jun 30, 2014
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; THYPARAMBIL, SHEENO; LIAO, WEI-LI
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 033215/0984 →
Assignment of Assignor's Interest
Jun 30, 2014
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; THYPARAMBIL, SHEENO; LIAO, WEI-LI
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 033215/0965 →
Assignment of Assignor's Interest
Jun 30, 2014
From: KRIZMAN, DAVID B.; LIAO, WEI-LI; THYPARAMBIL, SHEENO; HEMBROUGH, TODD
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 033215/0859 →
Assignment of Assignor's Interest
May 4, 2016
From: EITNER, CASIMIR P.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 038458/0535 →
Assignment of Assignor's Interest
May 5, 2016
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; LIAO, WEI-LI; THYPARAMBIL, SHEENO
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 038482/0366 →
Release of Security Interest
May 16, 2016
From: CALIFORNIA CAPITAL EQUITY LLC; NANT CAPITAL LLC
To: EXPRESSION PATHOLOGY INCORPORATED
Reel/Frame 038609/0312 →
Assignment of Assignor's Interest
Jul 12, 2017
From: KRIZMAN, DAVID B.; HEMBROUGH, TODD; THYPARAMBIL, SHEENO
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 042982/0071 →
Assignment of Assignor's Interest
Apr 10, 2019
From: DARFLER, MARLENE M.; KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 048849/0354 →
Assignment of Assignor's Interest
May 10, 2019
From: KRIZMAN, DAVID B.
To: EXPRESSION PATHOLOGY, INC.
Reel/Frame 049136/0710 →